Hims & Hers Q1 revenue up 88% to $190.8M; raises FY2023 guidance

Hims & Hers Health, Inc.

2023-Q1 EPS reported -$0.05 revenue$190,770,000

Revenue $190.8M (+88% YoY); net loss narrowed to $10.1M from $16.3M; adj. EBITDA $6.1M vs -$6.1M.
Subscribers 1.2M (+87% YoY); monthly online revenue per subscriber $55 (+6%); AOV $90 (+15%).
Gross margin improved to 80% from 74%.
Raises FY2023 revenue guidance to $810M-$830M; adj. EBITDA guidance to $25M-$30M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Hims & Hers Health, Inc. reported the first quarter ended March 31, 2023 results: revenue $190.8 million, net income $(10.1) million. Guidance raised.

Period: the first quarter ended March 31, 2023
Revenue: $190.8 million
Net income: $(10.1) million
Guidance: raised
Result: reported results

Exact text from the filing

Hims & Hers Health, Inc. Reports First Quarter 2023 Financial Results and Raises Full Year 2023 Outlook Revenue of $190.8 million, up 88% year-over-year in Q1 2023 Net loss of $10.1 million; Adjusted EBITDA profitability of $6.1 million in Q1 2023 Subscribers grew to over 1.2 million, up 87% year-over-year in Q1 2023 Raises full year 2023 revenue guidance to a range of $810 million to $830 million and Adjusted EBITDA guidance to a range of $25 million to $30 million

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Hims & Hers Health, Inc. filing history →

Source: SEC EDGAR

accession 0001773751-23-000123

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.